SlidesetHIVRSVInnovations in HIV Therapeutics 2022 - Asia-Pacific EditionImplementation Considerations - Heather-Marie Schmidt, BMedSc (Hon), MPH, PhDView Slideset
SlidesetHIVRSVInnovations in HIV Therapeutics 2022 - Asia-Pacific EditionClinical Considerations: What Have We Learned? - Fiona Cresswell, PhD, MBChB, BSc, DTM&H, PGCert Epi, DipHIVView Slideset
VideoHIVRSVInnovations in HIV Therapeutics 2022 - Asia-Pacific EditionIntroduction: Access and Advocacy - Giten KhwairakpamView Video
VideoHIVRSVInnovations in HIV Therapeutics 2022 - Asia-Pacific EditionPRO - Dariusz Piotr Olszyna, MD, PhD, FAMSView Video
VideoHIVRSVInnovations in HIV Therapeutics 2022 - Asia-Pacific EditionImplementation Considerations - Heather-Marie Schmidt, BMedSc (Hon), MPH, PhDView Video
VideoHIVRSVInnovations in HIV Therapeutics 2022 - Asia-Pacific EditionWhat Is in the Pipeline? (Models of Delivery) - Marta Boffito, MD, PhD, FRCPView Video
VideoHIVRSVInnovations in HIV Therapeutics 2022 - Asia-Pacific EditionCON - Jakkrapatara Boonruang, MDView Video
VideoHIVRSVInnovations in HIV Therapeutics 2022 - Asia-Pacific EditionClinical Considerations: What Have We Learned? - Fiona Cresswell, PhD, MBChB, BSc, DTM&H, PGCert EpiView Video
VideoHIVRSVInnovations in HIV Therapeutics 2022 - Asia-Pacific EditionPharmacological Considerations: Injections, Implants, Microneedles - Charles Flexner, MDView Video
GBGeorg BehrensMD, PhDSlidesetHIVRSVHIV Glasgow 2022 Symposium - The Devil Wears GP120Clinical Data from the GP120 Inhibitor Temsavir and its Relevance to Immune Reconstitution and HIV Associated Inflammation - Georg Behrens, MD, PhDView Slideset
JTJohn ThornhillPhD, MB BCh, BMed SciSlidesetHIVRSVHIV Glasgow 2022 Symposium - The Devil Wears GP120Immune Dysregulation – a Remaining Challenge in HIV Medicine - John Thornhill, PhD, MB BCh, BMed SciView Slideset
AFAndrés FinziPhDSlidesetHIVRSVHIV Glasgow 2022 Symposium - The Devil Wears GP120Temsavir Blocks HIV-1 Soluble GP120-induced Immunomodulatory Activities - Andrés Finzi, PhDView Slideset
